These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 18675144)

  • 41. Prevention of pertussis--are we failing?
    Brunell PA
    Pediatrics; 1985 Oct; 76(4):627-9. PubMed ID: 4047810
    [No Abstract]   [Full Text] [Related]  

  • 42. Influence of parental knowledge and opinions on 12-month diphtheria, tetanus, and pertussis vaccination rates.
    Lewis T; Osborn LM; Lewis K; Brockert J; Jacobsen J; Cherry JD
    Am J Dis Child; 1988 Mar; 142(3):283-6. PubMed ID: 3344714
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Knowledge, attitude, and practices with regard to adult pertussis vaccine booster in travelers.
    Wilder-Smith A; Boudville I; Earnest A; Heng SL; Bock HL
    J Travel Med; 2007; 14(3):145-50. PubMed ID: 17437469
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nosocomial pertussis: costs of an outbreak and benefits of vaccinating health care workers.
    Calugar A; Ortega-Sánchez IR; Tiwari T; Oakes L; Jahre JA; Murphy TV
    Clin Infect Dis; 2006 Apr; 42(7):981-8. PubMed ID: 16511764
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Examining the benefit of vaccinating adults against pertussis.
    Olyarchuk LD; Willoughby D; Davis SC; Newsom SA
    J Am Acad Nurse Pract; 2012 Oct; 24(10):587-94. PubMed ID: 23006017
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Economic analysis of pertussis illness in the Dutch population: implications for current and future vaccination strategies.
    de Greeff SC; Lugnér AK; van den Heuvel DM; Mooi FR; de Melker HE
    Vaccine; 2009 Mar; 27(13):1932-7. PubMed ID: 19368774
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Introduction of tetanus toxoid and reduced diphtheria toxoid vaccines in the United States.
    Mink CM
    Pediatr Infect Dis J; 2006 Apr; 25(4):363-4. PubMed ID: 16567991
    [No Abstract]   [Full Text] [Related]  

  • 48. Impact of routine vaccination with a pertussis toxoid vaccine in Denmark.
    Hviid A; Stellfeld M; Andersen PH; Wohlfahrt J; Melbye M
    Vaccine; 2004 Sep; 22(27-28):3530-4. PubMed ID: 15315832
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of changing from whole-cell to acellular pertussis vaccine on the epidemiology of hospitalized children with pertussis in Canada.
    Bettinger JA; Halperin SA; De Serres G; Scheifele DW; Tam T
    Pediatr Infect Dis J; 2007 Jan; 26(1):31-5. PubMed ID: 17195702
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reactogenicity of diphtheria, tetanus and pertussis vaccine in primary vaccination of infants and revaccination of schoolchildren.
    Adam E; Burian V; Kubátová E; Kratochvílová M; Hejdová E
    J Hyg Epidemiol Microbiol Immunol; 1967; 11(1):90-103. PubMed ID: 6070337
    [No Abstract]   [Full Text] [Related]  

  • 51. Prevention of pertussis in adolescents and young adults.
    Paul Y
    Indian Pediatr; 2009 Nov; 46(11):1024; author reply 1024. PubMed ID: 19955588
    [No Abstract]   [Full Text] [Related]  

  • 52. Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands.
    de Greeff SC; Mooi FR; Schellekens JF; de Melker HE
    Pediatr Infect Dis J; 2008 Mar; 27(3):218-23. PubMed ID: 18277916
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Boostrix: a reduced-dose acellular pertussis vaccine for use in adolescents and adults.
    Li WC; Wu TZ; Huang YC; Huang LM
    Expert Rev Vaccines; 2009 Oct; 8(10):1317-27. PubMed ID: 19803753
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Reactions after immunization with the triple vaccine against diphtheria, tetanus, and pertussis].
    Burianová B; Hegerová H; Hybásková J; Malický J; Průchová J; Puzanová L; Vlcek J
    Cesk Pediatr; 1981 Nov; 36(11):646-7. PubMed ID: 7318011
    [No Abstract]   [Full Text] [Related]  

  • 55. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.
    Zangwill KM; Eriksen E; Lee M; Lee J; Marcy SM; Friedland LR; Weston W; Howe B; Ward JI
    Pediatrics; 2008 Dec; 122(6):e1179-85. PubMed ID: 19047220
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Primary immunization with a triple diphtheria-tetanus-whole cell pertussis vaccine in Iranian infants: an analysis of antibody response.
    Zarei S; Jeddi-Tehrani M; Akhondi MM; Zeraati H; Pourheidari F; Ostadkarampour M; Tavangar B; Shokri F
    Iran J Allergy Asthma Immunol; 2009 Jun; 8(2):85-93. PubMed ID: 19671937
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The laboratory evaluation os polyvalent vaccine against diphtheria, tetanus and whooping cough using the rat pad oedema test. I. The evaluation of local reactivity after administration of a combined vaccine.
    Demelová M; Francová D; Malý V
    J Hyg Epidemiol Microbiol Immunol; 1967; 11(3):368-78. PubMed ID: 5629952
    [No Abstract]   [Full Text] [Related]  

  • 58. The impact of pre-school booster vaccination of 4--6-year-old children on pertussis in 0--1-year-old children.
    Hviid A; Stellfeld M; Wohlfahrt J; Andersen PH; Melbye M
    Vaccine; 2006 Feb; 24(9):1401-7. PubMed ID: 16207504
    [TBL] [Abstract][Full Text] [Related]  

  • 59. IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: effect of vaccine antigen content.
    Hendrikx LH; Berbers GA; Veenhoven RH; Sanders EA; Buisman AM
    Vaccine; 2009 Nov; 27(47):6530-6. PubMed ID: 19729085
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pertussis: a disease affecting all ages.
    Gregory DS
    Am Fam Physician; 2006 Aug; 74(3):420-6. PubMed ID: 16913160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.